Genomind is a personalized medicine company in neuropsychiatry. It was founded by a psychiatrist, Dr. Ronald Dozoretz, and a neurologist, Dr. Jay Lombard, who share a common goal of wanting the best possible care for patients who suffer from psychiatric illness. k

MOBILion’s technology makes it easy to separate, identify and analyze the most challenging molecules that other instruments fail to detect. Our higher resolution, faster analysis and simpler workflows reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. We make today’s treatment’s safer and more effective, empower tomorrow’s disease prediction and diagnosis, and accelerate the development of new therapies.